CIBC Asset Management
NVO

CIBC Asset Management’s Novo Nordisk NVO Stock Holding History

CIBC Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
21,936
-1,357
-6% -$58.3K ﹤0.01% 725
2026
Q1 		$856K Sell
23,293
-1,194
-5% -$56.6K ﹤0.01% 715
2025
Q4 		$1.25M Sell
24,487
-9,539
-28% -$488K ﹤0.01% 685
2025
Q3 		$1.89M Sell
34,026
-55,857
-62% -$3.27M 0.01% 593
2025
Q2 		$6.15M Buy
89,883
+17,459
+24% +$1.19M 0.02% 379
2025
Q1 		$4.97M Sell
72,424
-1,123
-2% -$92.8K 0.02% 398
2024
Q4 		$6.25M Buy
73,547
+3,989
+6% +$431K 0.02% 369
2024
Q3 		$8.19M Buy
69,558
+2,494
+4% +$333K 0.03% 318
2024
Q2 		$9.57M Sell
67,064
-3,029
-4% -$401K 0.03% 269
2024
Q1 		$9M Sell
70,093
-270
-0.4% -$32.1K 0.03% 301
2023
Q4 		$7.28M Sell
70,363
-296
-0.4% -$29.3K 0.03% 309
2023
Q3 		$6.43M Buy
70,659
+141
+0.2% +$12.4K 0.03% 314
2023
Q2 		$5.71M Buy
70,518
+19,546
+38% +$1.6M 0.02% 344
2023
Q1 		$4.06M Sell
50,972
-2,786
-5% -$198K 0.02% 409
2022
Q4 		$3.64M Sell
53,758
-4,368
-8% -$256K 0.02% 414
2022
Q3 		$2.9M Buy
58,126
+432
+0.7% +$23.1K 0.01% 444
2022
Q2 		$3.21M Sell
57,694
-10,226
-15% -$567K 0.01% 406
2022
Q1 		$3.77M Buy
67,920
+62,478
+1,148% +$3.21M 0.01% 417
2021
Q4 		$305K Buy
5,442
+364
+7% +$19.7K ﹤0.01% 1066
2021
Q3 		$244K Sell
5,078
-846
-14% -$40.9K ﹤0.01% 1177
2021
Q2 		$248K Sell
5,924
-58,600
-91% -$2.27M ﹤0.01% 1121
2021
Q1 		$2.17M Buy
64,524
+50
+0.1% +$1.78K 0.01% 485
2020
Q4 		$2.25M Sell
64,474
-72,870
-53% -$2.52M 0.01% 462
2020
Q3 		$4.77M Sell
137,344
-4,650
-3% -$155K 0.02% 288
2020
Q2 		$4.65M Sell
141,994
-1,810
-1% -$57.8K 0.03% 273
2020
Q1 		$4.33M Sell
143,804
-26,180
-15% -$780K 0.03% 254
2019
Q4 		$4.92M Sell
169,984
-5,096
-3% -$141K 0.03% 263
2019
Q3 		$4.53M Sell
175,080
-5,200
-3% -$131K 0.03% 261
2019
Q2 		$4.6M Sell
180,280
-359,598
-67% -$8.89M 0.03% 257
2019
Q1 		$14.1M Buy
539,878
+44,216
+9% +$1.09M 0.09% 111
2018
Q4 		$11.4M Buy
+495,662
New +$11M 0.08% 107
2016
Q4 		– Sell
-16,280
Closed -$339K – 977
2016
Q3 		$339K Sell
16,280
-111,804
-87% -$2.77M ﹤0.01% 754
2016
Q2 		$3.44M Sell
128,084
-45,780
-26% -$1.26M 0.03% 264
2016
Q1 		$4.71M Sell
173,864
-13,260
-7% -$355K 0.04% 198
2015
Q4 		$5.43M Sell
187,124
-8,880
-5% -$246K 0.04% 170
2015
Q3 		$5.32M Buy
196,004
+15,264
+8% +$432K 0.04% 169
2015
Q2 		$4.95M Sell
180,740
-1,820
-1% -$51.2K 0.03% 205
2015
Q1 		$4.87M Sell
182,560
-4,720
-3% -$109K 0.03% 198
2014
Q4 		$3.96M Sell
187,280
-5,800
-3% -$130K 0.03% 225
2014
Q3 		$4.6M Buy
193,080
+540
+0.3% +$12.4K 0.03% 223
2014
Q2 		$4.45M Sell
192,540
-4,440
-2% -$98K 0.03% 242
2014
Q1 		$4.5M Buy
196,980
+41,380
+27% +$882K 0.03% 238
2013
Q4 		$2.88M Buy
155,600
+2,200
+1% +$38.3K 0.02% 309
2013
Q3 		$2.6M Sell
153,400
-72,300
-32% -$1.22M 0.02% 317
2013
Q2 		$3.5M Buy
+225,700
New +$3.76M 0.02% 245

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

CIBC Asset Management's NVO Position: Q2 2026 in Review

CIBC Asset Management reduced its Novo Nordisk (NVO) stake by 5.8% in Q2 2026, selling an estimated $58.3K and leaving 21,936 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #725.

CIBC Asset Management first reported a position in NVO in Q2 2013 and has held it in 45 quarters since. The position peaked at $14.1M in Q1 2019. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • CIBC Asset Management held 21,936 shares of Novo Nordisk worth $1.05M as of Q2 2026.
  • CIBC Asset Management sold 1,357 Novo Nordisk shares in Q2 2026, an estimated $58.3K.
  • Novo Nordisk made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #725 holding.
  • CIBC Asset Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 45 quarters since.
  • CIBC Asset Management's Novo Nordisk position peaked at $14.1M in Q1 2019.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.